Drug consumption in the first years of rheumatoid arthritis in France, the Netherlands, and Norway: A longitudinal study in the early nineties

Ludig, A., Guillemin, G., Chary-Valckenaere, I., Suurmeijer, T. P. B. M., Moum, T. & Heuvel, W. J. A. V. D., 2000, In : Scandinavian Journal of Rheumatology. 29, 6, p. 352 1 p.

Research output: Contribution to journalArticleAcademic

Copy link to clipboard


  • PDF-file

    Final publisher's version, 76 KB, PDF document

Objective: To analyse drug consumption in the first years of rheumatoid arthritis (RA) in France, the Netherlands, and Norway, in a longitudinal study between 1991 and 1993. Patients and Methods: The EURIDISS cohort followed up over three years included 695 RA subjects with less than 5 years disease duration. Clinical and biological parameters, drug consumption according to ATC classification, and use of local treatment were recorded. Results: In the Netherlands consumption of second-line treatment occurred early on, and remained constant over time. In France, it was consumed by half of the subjects and decreased during follow-up (p<0.001). In Norway, 50% of the subjects were on second-line treatment at the outset. NSAIDs rather than corticoids were the most widely consumed. Patients underwent frequently local treatments with decrease frequency of infiltrations over time (p<0.001). Conclusion: Second-line treatments were used in the first years of disease development, following varying sequences in the different countries.
Original languageEnglish
Pages (from-to)352
Number of pages1
JournalScandinavian Journal of Rheumatology
Issue number6
Publication statusPublished - 2000


  • drugs, consumption, treatment, rheumatoid arthritis

View graph of relations

Download statistics

No data available

ID: 14560836